Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review
Nutrients · 12.09.2025 · 17 (18) · 2942
DOI: 10.3390/nu17182942 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 12.09.2025. Verfasst von Gianmario Forcina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Woman, Child, and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pediatric Obesity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pediatric obesity represents a growing global health challenge, closely associated with increased cardiometabolic risk and long-term adverse outcomes. Although lifestyle modifications remain the cornerstone of treatment, sustained success is often limited. Emerging evidence suggests that the gut microbiota (GM) plays a pivotal role in the pathogenesis of obesity, influencing host metabolism, energy homeostasis, and systemic inflammation. This narrative review aims to provide a comprehensive and up-to-date overview of the complex interplay between GM and pediatric obesity, with a particular emphasis on microbiota-targeted interventions. These include probiotics, prebiotics, synbiotics, postbiotics, dietary modulation, and fecal microbiota transplantation (FMT). Findings from preclinical studies and early-phase clinical trials indicate that gut dysbiosis may contribute to obesity-related mechanisms, such as altered nutrient absorption, increased adiposity, and dysregulated appetite control. Interventions targeting the microbiota have shown promise in modulating inflammatory pathways and improving metabolic profiles. While preliminary findings underscore the potential of the GM as a novel adjunctive target in managing pediatric obesity, current evidence remains heterogeneous, and robust clinical pediatric data are limited. Further research is needed to clarify the therapeutic efficacy, safety, and long-term outcomes of microbiota-modulating strategies in children with obesity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Woman, Child, and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
ORCID-Profile: Gianmario Forcina, Pierluigi Di Filippo, Vittoria Frattolillo, Pierluigi Marzuillo, Anna Di Sessa
Zitieren
APA
Forcina, G., Di Filippo, P., De Biasio, D., Cesaro, F. G., Frattolillo, V., Massa, A., De Cesare, M., Marzuillo, P., Miraglia Del Giudice, E., & Di Sessa, A. (2025). Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review. Nutrients, 17(18), 2942. https://doi.org/10.3390/nu17182942
Vancouver
Forcina G, Di Filippo P, De Biasio D, Cesaro FG, Frattolillo V, Massa A, et al. Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review. Nutrients. 2025;17(18):2942. doi:10.3390/nu17182942
BibTeX
@article{Forcina2025,
author = {Forcina, Gianmario and Di Filippo, Pierluigi and De Biasio, Delia and Cesaro, Francesco Giustino and Frattolillo, Vittoria and Massa, Alessia and De Cesare, Maria and Marzuillo, Pierluigi and Miraglia Del Giudice, Emanuele and Di Sessa, Anna},
title = {Targeting the Gut Microbiota in Pediatric Obesity: A Paradigm Shift in Prevention and Treatment? A Comprehensive Review},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {18},
pages = {2942},
doi = {10.3390/nu17182942}
}
EUVIMED